The Complement System

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4615-7228-2_4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on the histamine metabolism and the complement system in hereditary angioneurotic edema.

  2009cited by this paper
• Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.

  1979cited by this paper
• C3e: an acidic fragment of human C3 with leukocytosis-inducing activity.

  1979cited by this paper
• Antibody Responses to a T Cell Dependent Antigen in C4 Deficiency

  1978cited by this paper
• The purification and properties of the second component of guinea-pig complement.

  1978cited by this paper
• Combined genetic deficiency of C6 and C7 in man.

  1978cited by this paper
• Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol.

  1978cited by this paper
• Activation of the Alternative Complement Pathway by Escherichia Coli: Resistance of Bound C3b to Inactivation by C3bINA and β1H

  1978cited by this paper
• Homozygous C2 deficiency with fulminant lupus erythematosus: severe nephritis via the alternative complement pathway.

  1978cited by this paper
• Activation of complement by mouse iga immune complexes. Abstr.

  1978cited by this paper
• Serum complement pattern in essential mixed cryoglobulinaemia.

  1978cited by this paper
• Human C4-binding protein. II. Role in proteolysis of C4b by C3b- inactivator

  1978cited by this paper
• Small vessel vasculitis caused by hepatitis B virus immune complexes. Small vessel vasculitis and HBsAG.

  1978cited by this paper
• Heterogeneity of the clinical syndrome in patients with systemic lupus erythematosus and genetic deficiency of the second complement component.

  1978cited by this paper
• Modulation of the antigenicity of C1r and C1s by C1 inactivator.

  1978cited by this paper
• Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.

  1978cited by this paper
• The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

  1978cited by this paper
• Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway.

  1978cited by this paper
• Lichen planus and discoid lupud erythematosus. Overlap syndrome associated with cryoglobulinemia and hypocomplementemia.

  1978cited by this paper
• Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

  1978cited by this paper
• Cutaneous necrotizing venulitis: a sequential analysis of the morphological alterations occurring after mast cell degranulation in a patient with a unique syndrome.

  1978cited by this paper
• Skin lesions in viral hepatitis: histologic and immunofluorescent findings.

  1978cited by this paper
• Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

  1978cited by this paper
• Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.

  1978cited by this paper
• Human C4-binding protein. I. Isolation and characterization

  1978cited by this paper
• A new function of the activated third component of complement: binding to C5, an essential step for C5 activation.

  1978cited by this paper
• Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

  1978cited by this paper
• Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.

  1978cited by this paper
• Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein‐Barr virus transformation of the cells

  1978cited by this paper
• Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.

  1978cited by this paper
• Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

  1977cited by this paper
• [Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test].

  1977cited by this paper
• Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.

  1977cited by this paper
• Characterization of a leukotactic factor derived from psoriatic scale

  1977cited by this paper
• Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

  1977cited by this paper
• C8 deficiency in a family with xeroderma pigmentosum. Lack of linkage to the HLA region.

  1977cited by this paper
• The isolation and structure of C4, the fourth component of human complement.

  1977cited by this paper
• Pathways of complement activation in chronic discoid lupus: serologic and immunofluorescence studies.

  1977cited by this paper
• Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.

  1977cited by this paper
• The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

  1977cited by this paper
• Genetic deficiency of the second component of complement (C2) associated with systemic lupus erythematosus. Relation of the complement abnormality and disease manifestations.

  1977cited by this paper
• Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.

  1977cited by this paper
• Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.

  1977cited by this paper
• Serum lipoproteins and C567-INH activity.

  1977cited by this paper
• Purification and structural analysis of the fourth component of human complement.

  1977cited by this paper
• Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.

  1977cited by this paper
• Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex.

  1977cited by this paper
• Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

  1977cited by this paper
• Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.

  1977cited by this paper
• C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.

  1976cited by this paper
• Control of the amplification convertase of complement by the plasma protein beta1H.

  1976cited by this paper
• Complement in inflammatory acne vulgaris.

  1976cited by this paper
• Skin lesions, angioedema, eosinophilia, and hypocomplementemia.

  1976cited by this paper
• The complement abnormalities of lipodystrophy.

  1976cited by this paper
• Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

  1976cited by this paper
• A case of unusual SLE related syndrome characterized by erythema multiforme, angioneurotic edema, marked hypocomplementemia, and Clq precipitins of the low molecular weight type.

  1976cited by this paper
• C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.

  1976cited by this paper
• Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.

  1976cited by this paper
• Association of partial lipodystrophy and Sjögren's syndrome.

  1976cited by this paper
• Detection of complement activation by counterimmunoelectrophoresis (CIE).

  1976cited by this paper
• The Natural Modulation of the Amplification Phase of Complement Activation

  1976cited by this paper
• Modulation of the alternative complement pathways by beta 1 H globulin

  1976cited by this paper
• A molecular concept of the properdin pathway.

  1976cited by this paper
• Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL).

  1976cited by this paper
• Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis.

  1976cited by this paper
• Vasculitis with urticaria, hypocomplementemia, and multiple system involvement.

  1976cited by this paper
• C1q deficiency associated with urticarial-like lesions and cutaneous vasculitis.

  1976cited by this paper
• Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.

  1976cited by this paper
• Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality.

  1976cited by this paper
• Alternative pathway complement activation: a possible mechanism inducing skin lesions in benign gonococcal sepsis

  1976cited by this paper
• The interrelationship between hypocomplementaemia, partial lipodystrophy and mesangiocapillary glomerulonephritis.

  1976cited by this paper
• The unactivated form of the first component of human complement, C1.

  1976cited by this paper
• Defective opsonization. A common immunity deficiency.

  1976cited by this paper
• Nephritic Factor: Its Structure and Function and Its Relationship to Initiating Factor of the Alternative Pathway

  1976cited by this paper
• Complement component profiles in urticaria, dermatitis herpetiformis, and alopecia areata

  1976cited by this paper
• Two distinct cellular patterns in cutaneous necrotizing angiitis.

  1976cited by this paper
• Effects of activated complement components on enzyme secretion by macrophages.

  1976cited by this paper
• Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

  1976cited by this paper
• Hereditary C2 deficiency: association with skin lesions resembling the discoid lesion of systemic lupus erythematosus.

  1976cited by this paper
• Serum immunoglobulin and complement levels in patients with psoriasis vulgaris.

  1976cited by this paper
• The alternative pathway of complement activation.

  1976cited by this paper
• Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

  1976cited by this paper
• Inherited C2 deficiency and systemic lupus erythematosus: studies on a family.

  1975cited by this paper
• Properdin: initiation of alternative complement pathway.

  1975cited by this paper
• Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes.

  1975cited by this paper
• Complete absence of the third component of complement in man.

  1975cited by this paper
• Cleavage products of C4b produced by enzymes in human serum.

  1975cited by this paper
• Evidence for a serum inhibitor of Clq.

  1975cited by this paper
• A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.

  1975cited by this paper
• Selective deficiency of the second component of complement in a patient with anaphylactoid purpura.

  1975cited by this paper
• Enzymatic activity of the second component of complement.

  1975cited by this paper
• Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.

  1975cited by this paper
• Hereditary complement (C2) deficiency with dermatomyositis.

  1975cited by this paper
• Hereditary deficiency of the seventh component of complement.

  1975cited by this paper
• Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.

  1975cited by this paper
• Specificity of human lymphocyte complement receptors

  1975cited by this paper
• Hereditary C2 deficiency: Genetic studies and association with the HL-A system

  1975cited by this paper
• Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

  1975cited by this paper
• Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum

  1975cited by this paper
• Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.

  1975cited by this paper

• The role of complement in phototoxic reactions

  2005cites this paper
• The role of complement-derived mediators in inflammatory skin diseases

  2004cites this paper
• Receptors for complement of Langerhans cells.

  1980cites this paper